Diligence memo · auto-generated · as of July 2, 2026
Willowcroft Pharm Inc
Willowcroft Pharm Inc looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Willowcroft Pharm Inc operates in Pharmaceuticals, based in DENVER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Willowcroft Pharm Inc has raised $5.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on —.
Valuation (modeled)modeled
Provath models Willowcroft Pharm Inc at approximately $11M (range $5.7M–$14M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.08× the median modeled value of Series A Pharmaceuticals companies (418 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 42% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 18% of those peers.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.